06 September 2022

Safety update

Reference: CIR-2022-00000188

To all Health, facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

Medical Product Field Safety Safety update for TNF blockers - Simponi ® (Golimumab)

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

 

Supporting Documents:

تحديث التحذيرات على الصنف الدوائي محصرات (TNF) Simponi (Golimumab) ---.pdf:

View Document